Javascript must be enabled to continue!
Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours
View through CrossRef
OBJECTIVEThe molecular mechanisms underlying ACTH‐secreting tumour formation remain unknown. Transmembrane signalling pathways play an important role in several endocrine disorders including pituitary tumours. To investigate the role of the pituitary vasopressin (V3) receptor (R) in ACTH‐secreting tumours we have qualitatively and quantitatively analysed its mRNA.DESIGNRT–PCR, denaturing gradient gel electrophoresis and S1 nuclease protection experiments were used to analyse V3 mRNA structure in ACTH‐secreting tumours. We also developed a competitive RT–PCR system to compare the levels of expression of POMC, V3 and CRH‐R genes. This system used as competitor a single mutant template (termed multi‐mutant) containing primers for the three genes flanking an unrelated core sequence allowing multiple quantifications from the same cDNA preparations. We analysed 12 normal pituitaries, 15 corticotroph pituitary adenomas and 6 ACTH‐secreting bronchial carcinoids.RESULTSThe V3 mRNA structure and sequence were found to be identical in normal and tumoural pituitary indicating that the tumoural Vs mRNA codes for a normal receptor. POMC RT–PCR signals in the pituitary tumour group were approximately 7‐fold higher than in the normal pituitary group. Similarly, V3 and CRH‐R signal were increased in pituitary tumors (mean ± SEM: 5.87 × 10−6 ± 1.73 × 10−6, and 2.33 × 10−4 ± 1.4 × 10−4, respectively), when compared to normal pituitaries (1.19 × 10−7 ± 2.39 × 10−8, and 1.7 × 10−6 ± 4.65 × 10−7, respectively) suggesting that these two genes are expressed at very high levels in corticotroph tumours. When expressed relative to the corresponding POMC signals, increases in V3 and CRH‐R signals reached 49‐fold and 137‐fold, respectively, in pituitary tumours. In ACTH‐secreting bronchial carcinoids V3 gene expression level was also higher than in normal pituitary, whereas CRH‐R signals were detected in only 4 of the 6 tumours with wide variations.CONCLUSIONOur results show that both vasopressin and CRH receptor genes are overexpressed in ACTH‐secreting pituitary tumours. They suggest that overexpression of G protein‐coupled receptors may be an additional mechanism through which membrane receptors may play a role in human tumours.
Title: Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumours
Description:
OBJECTIVEThe molecular mechanisms underlying ACTH‐secreting tumour formation remain unknown.
Transmembrane signalling pathways play an important role in several endocrine disorders including pituitary tumours.
To investigate the role of the pituitary vasopressin (V3) receptor (R) in ACTH‐secreting tumours we have qualitatively and quantitatively analysed its mRNA.
DESIGNRT–PCR, denaturing gradient gel electrophoresis and S1 nuclease protection experiments were used to analyse V3 mRNA structure in ACTH‐secreting tumours.
We also developed a competitive RT–PCR system to compare the levels of expression of POMC, V3 and CRH‐R genes.
This system used as competitor a single mutant template (termed multi‐mutant) containing primers for the three genes flanking an unrelated core sequence allowing multiple quantifications from the same cDNA preparations.
We analysed 12 normal pituitaries, 15 corticotroph pituitary adenomas and 6 ACTH‐secreting bronchial carcinoids.
RESULTSThe V3 mRNA structure and sequence were found to be identical in normal and tumoural pituitary indicating that the tumoural Vs mRNA codes for a normal receptor.
POMC RT–PCR signals in the pituitary tumour group were approximately 7‐fold higher than in the normal pituitary group.
Similarly, V3 and CRH‐R signal were increased in pituitary tumors (mean ± SEM: 5.
87 × 10−6 ± 1.
73 × 10−6, and 2.
33 × 10−4 ± 1.
4 × 10−4, respectively), when compared to normal pituitaries (1.
19 × 10−7 ± 2.
39 × 10−8, and 1.
7 × 10−6 ± 4.
65 × 10−7, respectively) suggesting that these two genes are expressed at very high levels in corticotroph tumours.
When expressed relative to the corresponding POMC signals, increases in V3 and CRH‐R signals reached 49‐fold and 137‐fold, respectively, in pituitary tumours.
In ACTH‐secreting bronchial carcinoids V3 gene expression level was also higher than in normal pituitary, whereas CRH‐R signals were detected in only 4 of the 6 tumours with wide variations.
CONCLUSIONOur results show that both vasopressin and CRH receptor genes are overexpressed in ACTH‐secreting pituitary tumours.
They suggest that overexpression of G protein‐coupled receptors may be an additional mechanism through which membrane receptors may play a role in human tumours.
Related Results
Vasopressin‐induced intracellular Ca2+ increase in isolated rat supraoptic cells.
Vasopressin‐induced intracellular Ca2+ increase in isolated rat supraoptic cells.
1. The intracellular Ca2+ concentration ([Ca2+]1) was monitored in single magnocellular neurones freshly isolated from rat supraoptic nucleus. Application of 100 nM vasopressin inc...
Polycystic Kidney Disease and the Vasopressin Pathway
Polycystic Kidney Disease and the Vasopressin Pathway
Vasopressin, also known as arginine vasopressin or antidiuretic hormone, plays a pivotal role in maintaining body homeostasis. Increased vasopressin concentrations, measured by its...
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells
Abstract
Background
The parathyroid calcium receptor determines parathyroid hormone secretion and the response of parathyroid hormone gene expr...
Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic sh...
Predictors of Vasopressin Responsiveness in Critically Ill Adults
Predictors of Vasopressin Responsiveness in Critically Ill Adults
Background: Vasopressin is commonly used as an adjunct vasopressor in shock. However, response to vasopressin varies among critically ill patients. Objective: To identify patient-s...
Pulmonary carcinoid tumours
Pulmonary carcinoid tumours
Key pointsPulmonary carcinoid tumours account for 2% of all lung tumours, with an increase in incidence due to more accurate diagnostic techniques.Carcinoid tumours are relatively ...
Physiology of invertebrate oxytocin and vasopressin neuropeptides
Physiology of invertebrate oxytocin and vasopressin neuropeptides
New findings
What is the topic of this review?This article describes the discovery and function of invertebrate oxytocin and vasopressin neuropeptides.
What advances does it highli...
Vasopressin in preeclampsia
Vasopressin in preeclampsia
<p>Preeclampsia is a devastating disorder of pregnancy characterized by high blood pressure, proteinuria, headache, renal glomerular endotheliosis, multi-organ system failure...

